
    
      Insulin resistance suppresses fasting ghrelin levels and impairs postprandial ghrelin
      suppression. Improved insulin sensitivity with a thiazolidinedione will raise ghrelin levels,
      enhance meal-related suppression, but not change the ratio of total to active ghrelin or
      result in an alteration of ghrelin structure.
    
  